Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows (Unaudited)

v3.23.1
Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows from Operating Activities:    
Net loss $ (5,849) $ (4,776)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:    
Depreciation and amortization 149 117
Provision (recoveries) for bad debts (17) 84
Provision for sales returns 0 60
Amortization of debt issuance costs 107 67
Stock-based compensation 691 209
Changes in operating assets and liabilities:    
Accounts receivable 700 (1,085)
Inventory (1,890) (1,682)
Prepaid expenses and other current assets 240 (186)
Accounts payable and accrued liabilities 303 (986)
Deferred revenue (92) 157
Net cash and cash equivalents used in operating activities (5,658) (8,021)
Cash Flows from Investing Activities:    
Purchases of property, plant, and equipment (587) (304)
Net cash and cash equivalents used in investing activities (587) (304)
Cash Flows from Financing Activities:    
Proceeds from the sale of common stock and pre-funded warrants 8,503 0
Proceeds from the exercise of common stock warrants 14 0
Net cash and cash equivalents provided by financing activities 8,517 0
Effect of exchange rate changes 79 (41)
(Decrease) increase in cash, cash equivalents and restricted cash 2,351 (8,366)
Cash, cash equivalents and restricted cash, beginning of period 4,181 30,175
Cash, cash equivalents and restricted cash, end of period 6,532 21,809
Supplemental cash flow disclosure:    
Cash paid for interest 470 377
Cash received for interest 2 10
Cash paid (received) for income taxes (14) 26
Cash paid for operating leases 68 66
Non-cash right-of-use assets obtained in exchange for lease obligation 464 444
Deemed dividend on preferred stock $ 0 $ 217